Related Experiment Video
Updated: May 19, 2026

Extracellular Vesicle Tissue Factor Activity Assay
Published on: December 29, 2023
[Detection of tissue factor-positive microparticles and its clinical significance in the haemostatic disorder]
Li-Li Zhou1, Yue Han, Qian Zhu
1Department of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China.
Abstract:
Objective of this study was to detect the level of tissue factor-positive microparticles (TF(+)MP) by flow cytometry (FCM) and to analyze its clinical significance in the haemostatic disorder. TF(+) MP was detected by FCM using antibody CD142-PE in 25 cases of acute promyelocytic leukemia (APL), 20 cases of hemostatic diseases and 20 healthy adults as controls. The differences of TF(+) MP between various groups were determined. The results showed that the level of TF(+) MP in the patients with thrombotic complications was significantly higher than that in the healthy adults (P < 0.05). The TF(+) MP level was higher in the patient with APL than that in the healthy adults, especially in course before therapy (P < 0.01), but the difference was not statistically significant in the patient with APL after therapy and the healthy adults. Among these patient with APL, the level of TF(+) MP in the 18 patients who complicated with disseminated intravascular coagulation (DIC) was also higher than that in the healthy adults (P < 0.05), but the level of TF(+) MP in the other 7 patients who did not complicate with DIC was similar before and after treatment. It is concluded that the method of TF(+) MP detection by FCM is feasible and simple, it is useful for the diagnosis of thrombotic disorder, and helps evaluation for the prognosis of APL patient.
Insights
Tissue factor-positive microparticles (TF(+)MP) detected by flow cytometry are elevated in patients with thrombotic complications and acute promyelocytic leukemia (APL). This method aids in diagnosing thrombotic disorders and prognosing APL.
Area of Science:
- Hematology
- Oncology
- Biochemistry
Context:
- Tissue factor-positive microparticles (TF(+)MP) play a role in hemostasis and thrombosis.
- Flow cytometry (FCM) is a method for detecting TF(+)MP.
- Acute promyelocytic leukemia (APL) is a hematologic malignancy associated with hemostatic complications.
Purpose:
- To detect the level of TF(+)MP by FCM.
- To analyze the clinical significance of TF(+)MP in hemostatic disorders.
- To evaluate TF(+)MP as a diagnostic and prognostic marker.
Summary:
- TF(+)MP levels were significantly higher in patients with thrombotic complications compared to healthy adults.
- APL patients, especially before therapy, showed elevated TF(+)MP levels.
- TF(+)MP levels were higher in APL patients with disseminated intravascular coagulation (DIC).
Impact:
- FCM detection of TF(+)MP is a feasible and simple method.
- TF(+)MP detection is useful for diagnosing thrombotic disorders.
- TF(+)MP levels can aid in evaluating the prognosis of APL patients.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...

